Agilus Diagnostics has appointed Vijender Singh as its Managing Director and Chief Executive Officer, marking a significant leadership transition for one of India’s leading diagnostic service providers. He succeeds Dr. Anand K, who has stepped down after nearly six years with the company to pursue opportunities outside the organisation.
Vijender Singh brings more than three decades of leadership experience across diagnostics, healthcare, consumer healthcare, and FMCG. He has built a strong reputation for driving business transformation, operational excellence, governance, and customer-centric growth while leading some of India’s most prominent healthcare organisations.
Before joining Agilus Diagnostics, Singh served as Chairman and Managing Director of Diagnum Healthcare, where he focused on strategic growth and business development. His leadership journey also includes key roles as Group CEO of Metropolis Healthcare, CEO of Healthians, and senior leadership positions at Dr. Lal PathLabs, where he played an instrumental role in expanding the company’s diagnostics network and contributing to its successful IPO. He has also held leadership roles at Jashvik Capital, Ranbaxy Consumer Healthcare, Bausch & Lomb, and Blow Plast.
Welcoming the appointment, Dr. Ashutosh Raghuvanshi, Managing Director & CEO of Fortis Healthcare and Chairman of Agilus Diagnostics, said Vijender Singh’s extensive experience in scaling diagnostic businesses and delivering operational excellence makes him well-positioned to lead the organisation’s next phase of growth. He added that Singh’s leadership will help accelerate innovation, strengthen customer experience, and reinforce Agilus Diagnostics’ position as one of India’s most trusted diagnostics brands.

Also Read: HealthTech Startup Plazza Raises $15 Million in Series A to Expand AI-Driven Pharmacy Network
Commenting on his appointment, Vijender Singh said he is excited to join Agilus Diagnostics at a time when the diagnostics industry is undergoing rapid transformation. He emphasised his commitment to strengthening the company’s market leadership, expanding access to high-quality diagnostic services, enhancing operational efficiency, and creating long-term value for patients and stakeholders.
A subsidiary of Fortis Healthcare, Agilus Diagnostics operates one of India’s largest diagnostics networks with more than 410 laboratories, over 3,700 customer touchpoints, and services spanning more than 1,000 cities across the country. The leadership appointment aligns with the company’s long-term strategy to drive innovation, expand its footprint, and strengthen its position in India’s rapidly evolving diagnostics sector.
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
